Disparities in germline testing among racial minorities with prostate cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disparities in germline testing among racial minorities with prostate cancer
Authors
Keywords
-
Journal
PROSTATE CANCER AND PROSTATIC DISEASES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-14
DOI
10.1038/s41391-021-00469-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for Clinicians
- (2021) Axel S. Merseburger et al. EUROPEAN UROLOGY
- Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients
- (2021) Rachel A. Sabol et al. PROSTATE
- Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer
- (2021) Elisa M. Ledet et al. PROSTATE
- Germline alterations among Hispanic men with prostate cancer.
- (2021) Justin Shaya et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized controlled trial of video-education or in-person genetic counseling for men with prostate cancer (ProGen).
- (2020) Huma Q. Rana et al. JOURNAL OF CLINICAL ONCOLOGY
- Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions
- (2020) Emily M. Rencsok et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
- (2020) Veda N. Giri et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid deployment of a telemedicine care model for genetics and metabolism during COVID ‐19
- (2020) Natasha Shur et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
- (2020) William T. Lowrance et al. JOURNAL OF UROLOGY
- Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II
- (2020) William T. Lowrance et al. JOURNAL OF UROLOGY
- Racial Differences in Genomic Profiling of Prostate Cancer
- (2020) Brandon A. Mahal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disparities in precision medicine—Examining germline genetic counseling and testing patterns among men with prostate cancer
- (2020) Hala T. Borno et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Global Disparities in Breast Cancer Genetics Testing, Counselling and Management
- (2019) C. H. Yip et al. WORLD JOURNAL OF SURGERY
- Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
- (2019) Piper Nicolosi et al. JAMA Oncology
- Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2019) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- New name for breast-cancer syndrome could help to save lives
- (2019) Colin C. Pritchard NATURE
- Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
- (2019) Ian D. Davis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
- (2019) Kim N. Chi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European
- (2019) Mesaki K. Ndugga-Kabuye et al. Familial Cancer
- Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
- (2019) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors associated with oncologist discussions of the costs of genomic testing and related treatments
- (2019) K Robin Yabroff et al. JNCI-Journal of the National Cancer Institute
- Ethnic disparities among men with prostate cancer undergoing germline testing
- (2019) Daniel Hyuck-Min Kwon et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Genetic counseling among minority populations in the era of precision medicine
- (2018) Chanita H. Halbert et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Genetic testing for hereditary prostate cancer: Current status and limitations
- (2018) Jun Tu Zhen et al. CANCER
- Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
- (2018) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study
- (2018) Jonathan E. Katz et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer
- (2018) Marieke J. Krimphove et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men
- (2018) Charles R. Rogers et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing
- (2018) Veda N. Giri et al. PROSTATE
- Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis
- (2018) Ryan W. Dobbs et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
- (2017) Rong Na et al. EUROPEAN UROLOGY
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study
- (2017) Felix M. Chinea et al. Oncotarget
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Racial/Ethnic Disparities in Genomic Sequencing
- (2016) Daniel E. Spratt et al. JAMA Oncology
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review of factors that act as barriers to patient referral to genetic services
- (2014) Türem Delikurt et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- What hinders minority ethnic access to cancer genetics services and what may help?
- (2013) Anna Allford et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The Need to Build Trust: A Perspective on Disparities in Genetic Testing
- (2013) Kalyn Saulsberry et al. Genetic Testing and Molecular Biomarkers
- Physicians and Implicit Bias: How Doctors May Unwittingly Perpetuate Health Care Disparities
- (2013) Elizabeth N. Chapman et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Masculinity, Medical Mistrust, and Preventive Health Services Delays Among Community-Dwelling African-American Men
- (2010) Wizdom Powell Hammond et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer
- (2010) Ganna Chornokur et al. PROSTATE
- Mistrust of Health Care Organizations Is Associated with Underutilization of Health Services
- (2009) Thomas A. LaVeist et al. HEALTH SERVICES RESEARCH
- Association of Insurance with Cancer Care Utilization and Outcomes
- (2008) E. Ward et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Racial disparities in cancer therapy
- (2008) Cary P. Gross et al. CANCER
- Differential use of available genetic tests among primary care physicians in the United States: results of a national survey
- (2008) Alexandra E Shields et al. GENETICS IN MEDICINE
- Racial Differences in Treatment of Early-Stage Prostate Cancer
- (2008) Kathryn E. Richert-Boe et al. UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started